COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,286 Articles (22,759 medRxiv, 8,527 bioRxiv)

Most recent first Previous |  Page 54: Articles 531-540  | Next

Genomic and epidemiologic characteristics of SARS-CoV-2 persistent infections in California, January 2021 - July 2023
Bell, J. M., Elder, J., Ryder, R., Smith, E. A., Scribner, M., Gilliam, S., Borthwick, D., Crumpler, M., Skarbinski, J., Morales, C., Wadford, D. A.
10.1101/2025.07.14.664650 — Posted: 2025-07-16
Mouse Adapted Omicron BA.5 Induces A Fibrotic Lung Disease Phenotype in BALB/c Mice
Powers, J. M., Leist, S. R., Suryadevara, N., Zost, S., Binshtein, E., Abdelgadir, A., Mallory, M. L., Edwards, C. E., Gully, K. L., Hubbard, M. L., Zweigart, M. R., Bailey, A. B., Sheahan, T. P., Crowe, J. E., Montgomery, S. A., Harkema, J. R., Baric, R. S.
10.1101/2025.07.16.665104 — Posted: 2025-07-16
Some alterations in vitamin D metabolism during the COVID-19 pandemic
Dobler, D., Coralizzi, A. I., Garrone, N. A., Cozza Buccaro, E. N.
10.1101/2025.07.08.25331143 — Posted: 2025-07-15
Identification of within-host deletions in domain 0 of the spike gene of highly pathogenic feline coronavirus type 2 from the United States
Olarte-Castillo, X. A., Schlecht, A., Sams, K. L., Goodman, L. B., Whittaker, G.
10.1101/2025.07.12.664542 — Posted: 2025-07-15
Reproducible detection of antigen-specific T cells and Tregs via standardized and automated activation-induced marker assay workflows
Halvorson, T., Boucher, G., Yokosawa, D., Huang, J. Q., Garcia, R., Sanderink, L., Chen, L., Liu, L., Fajardo-Despaigne, J. E., Halvorson, J., Brinkman, R., Vercauteren, S., Lesage, S., Bramson, J., Rioux, J. D., Ivison, S., Levings, M. K.
10.1101/2025.07.15.664847 — Posted: 2025-07-15
Predicting Future SARS-CoV-2 Mutations using Deep Learning
Ayaz, H., Ibrahimzada, A. R., Adebali, O., Fejzullahu, A., Azgari, C., Baysan, M., Buyukbingol, M. E., Demir, G., Karlik, E., Ozpolat, B., CAKMAK, A.
10.1101/2025.07.12.664533 — Posted: 2025-07-15
Integrated Systems Vaccinology Reveals Distinct Metabolic Responses to SARS-CoV-2 Infection and DNA-Based Vaccines in Ferrets
Ahlen, G., Ambikan, A., Mikaeloff, F., Rezene, S., Yan, J., Nikouyan, N., Revanna, C. B., Appelberg, S., Mirazimi, A., Sallberg, M., Neogi, U., Gupta, S.
10.1101/2025.07.11.664150 — Posted: 2025-07-14
The effect of pre-booked appointments on COVID-19 vaccine uptake during the 2023 autumn campaign in the Netherlands: a regression discontinuity analysis
Haverkate, M., van de Kassteele, J., van den Hof, S., Sanders, J., Lambooij, M., de Bruin, M., de Melker, H., Hahne, S.
10.1101/2025.07.10.25331000 — Posted: 2025-07-11
Integrating genomic data into test-negative designs for estimating lineage-specific COVID-19 vaccine effectiveness
Ma, K., Surie, D., Dean, N. E., Paden, C. R., Thornburg, N., Dawood, F. S.
10.1101/2025.07.10.25331291 — Posted: 2025-07-11
The Unreliability of Estimated Release Dates in Hospital Drug Shortage Management: A Case Study of Hospital Pharmacy Operations During the COVID-19 Pandemic
Chicoine, N., Griffin, J.
10.1101/2025.07.10.25331166 — Posted: 2025-07-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).